Trials / Completed
CompletedNCT04103099
Impact of HLNatural Immune Supplement on Colds
Evaluation of the Impact of the HLNatural, Inc. Immune Support Product in Reducing the Length of Cold Symptoms in Adults Suffering From the Common Cold
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Hawthorne Effect Inc. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
According to the Centers of Disease Control and Prevention (CDC) adults will have an average of 2-3 colds per year. Most colds will last approximately 7-10 days. The symptoms of colds could include cough, sore throat, runny nose, body aches, fevers, headaches and fatigue. A cold can affect your activity such as going to work, interrupting your sleep and your day to day activities. The test product contains all natural ingredients which have been combined into a powder to be taken in water at the sign of a cold.
Detailed description
At the onset of a cold, mix 1 packet of the drink-mix product in 6-8 oz. of hot water. Drink the drink mix twice a day until symptoms are gone or 18 days, whichever comes first. 1. Complete the screening survey. 2. Sign the eConsent if approved. 3. Complete the baseline survey, demographic form, and Medication and Supplements form. 4. Receive test product and log into study portal and complete supplement receipt form. This will mark the start of your participation in this study. 5. Once you have a cold, complete the symptom survey. 6. Take test product. 7. Write down any adverse or ill effects any time after taking the test product. 8. Record if you took any additional medications or supplements daily during the course of your cold. 9. Note any final adverse events and complete the exit form.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | HLNatural Immune | Vitamin C, Echinacea, Ivy Extract, Zinc, Ginger and Turmeric in a powder form mixed with water |
Timeline
- Start date
- 2019-10-16
- Primary completion
- 2020-08-15
- Completion
- 2020-08-15
- First posted
- 2019-09-25
- Last updated
- 2021-11-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04103099. Inclusion in this directory is not an endorsement.